NLRP1 (Q9C000) variants and mutations
NLRP1 (also known as Q9C000) is a human protein-coding gene encoding a NACHT, LRR and PYD domains-containing protein 1 protein. It can assemble an inflammasome that activates caspase-1 and inflammatory cytokines in response to cellular danger, with prominent functions in skin and epithelial immunity. Gain-of-function variants cause autoinflammatory skin syndromes and can increase susceptibility to inflammatory disease. This analysis covers 2,168 NLRP1 variants and mutations. Of these, 67% have computational variant effect predictions. Disease context includes corneal intraepithelial dyskeratosis-palmoplantar hyperkeratosis-laryngeal dyske, autoinflammation with arthritis and dyskeratosis, and Corneal intraepithelial dyskeratosis with palmoplantar hyperkeratosis and laryng. Example NLRP1 variants include A2V, G3S, and G4A.
Variant analysis overview
- Gene: NLRP1
- Protein: Q9C000
- UniProt accession: Q9C000
- Organism: Homo sapiens
- Variants analyzed: 2168
- Variant scope: all variants
- Completed: 2026-08-20
Variant and mutation evidence
- Variant composition: 1,993 unspecified-consequence records; 2 stop retained variant; 75 synonymous variants; 83 missense variants; 1 stop lost; 8 frameshift variants; 5 stop-gained variants; 1 splice-region variants
- Prediction scores: 1,444 variants have prediction scores (67% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: corneal intraepithelial dyskeratosis-palmoplantar hyperkeratosis-laryngeal dyske, autoinflammation with arthritis and dyskeratosis, Corneal intraepithelial dyskeratosis with palmoplantar hyperkeratosis and laryng, respiratory papillomatosis, juvenile recurrent, congenital, vitiligo, DNA methylation, eye disorder, migraine disorder, digestive system neoplasm, Chorioretinal scar, male infertility, hereditary disease.
Protein structure and variant hotspots
- Protein features: 4 domains; 1 binding sites; 16 post-translational modification sites.
- Structural context: 1,198 variants have structural context.
- PTM context: 18 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable NLRP1 variants
Examples include A2V, G3S, G4A, G4R, A5G, A5S, W6C, W6L. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- A2V (p.Ala2Val), rs2151833072, ClinGen CA397391396, ClinVar RCV001999359, Ensembl rs2151833072, CADD 22.90, PolyPhen-2 0.96, Uncertain significance, not provided
- G3S (p.Gly3Ser), TOPMed rs1906004708, CADD 0.02, PolyPhen-2 0.00
- G4A (p.Gly4Ala), NCI-TCGA Cosmic COSV9933, cosmic curated COSV99333, Variant assessed as somatic; moderate impact.
- G4R (p.Gly4Arg), rs201312429, ClinGen CA8327663, NCI-TCGA Cosmic COSV5255, cosmic curated COSV52559, CADD 0.23, PolyPhen-2 0.00, Uncertain significance, Inborn genetic diseases; not provided
- A5G (p.Ala5Gly), Ensembl rs1906003121
- A5S (p.Ala5Ser), TOPMed rs1357536300, gnomAD rs1357536300, CADD 9.92, PolyPhen-2 0.04, Uncertain significance, not provided
- W6C (p.Trp6Cys), gnomAD rs1382774965
- W6L (p.Trp6Leu), cosmic curated COSV10728, CADD 10.50, PolyPhen-2 0.01
- W6P (p.Trp6Pro), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- W6R (p.Trp6Arg), rs1451113448, ClinGen CA397391378, ClinVar RCV001968831, TOPMed rs1451113448, CADD 4.19, PolyPhen-2 0.00, Uncertain significance, not provided
- R8C (p.Arg8Cys), rs771011373, ClinGen CA287293763, ClinVar RCV003670393, gnomAD rs771011373, CADD 21.40, PolyPhen-2 0.79, Uncertain significance, not specified; not provided
- R8H (p.Arg8His), rs200371400, ClinGen CA8327662, cosmic curated COSV52581, ClinVar RCV002581562, CADD 9.06, PolyPhen-2 0.65, Uncertain significance, not provided
- R8L (p.Arg8Leu), NCI-TCGA TCGA novel, CADD 0.20, PolyPhen-2 0.25, Variant assessed as somatic; moderate impact.
- R8S (p.Arg8Ser), rs771011373, ClinGen CA397391363, ClinVar RCV002639616, gnomAD rs771011373, CADD 9.57, PolyPhen-2 0.25, Uncertain significance, not provided
- L9P (p.Leu9Pro), Ensembl rs1597494293
- A10G (p.Ala10Gly), Ensembl rs1905999757
- A10S (p.Ala10Ser), rs2508145416, ClinGen CA397391354, ClinVar RCV003575182, Uncertain significance, not provided
- C11S (p.Cys11Ser), cosmic curated COSV10728, gnomAD rs1317931422
- E14K (p.Glu14Lys), TOPMed rs1414256114, gnomAD rs1414256114, CADD 19.10, PolyPhen-2 0.90
- E14Q (p.Glu14Gln), TOPMed rs1414256114, gnomAD rs1414256114, CADD 21.50, PolyPhen-2 0.95
- K17R (p.Lys17Arg), TOPMed rs1905998437
- K18* (p.Lys18Ter), rs1165171576, ClinGen CA397391294, ClinVar RCV003860749, AlphaMissense 0.17, MetaLR 0.15, Uncertain significance
- K18E (p.Lys18Glu), gnomAD rs1165171576, AlphaMissense 0.17, MetaLR 0.15
- E19G (p.Glu19Gly), rs2508145090, ClinGen CA397391285, ClinVar RCV002903420, Uncertain significance, not provided
- E19K (p.Glu19Lys), ExAC rs754678021, gnomAD rs754678021, CADD 16.00
- L21P (p.Leu21Pro), gnomAD rs1189115179, CADD 22.70, PolyPhen-2 0.23
- E23G (p.Glu23Gly), cosmic curated COSV52579
- E23K (p.Glu23Lys), cosmic curated COSV10457, Ensembl rs868216905, CADD 15.00, PolyPhen-2 0.03
- Q25H (p.Gln25His), NCI-TCGA TCGA novel, CADD 16.50, PolyPhen-2 0.80, Variant assessed as somatic; moderate impact.
- Q25K (p.Gln25Lys), cosmic curated COSV99335
- L26F (p.Leu26Phe), TOPMed rs1905996068
- L28F (p.Leu28Phe), rs980793433, ClinGen CA287293723, ClinVar RCV002610426, ClinVar RCV005445795, CADD 15.20, PolyPhen-2 0.11, Conflicting interpretations, Inborn genetic diseases; not provided
- A29S (p.Ala29Ser), TOPMed rs971095282, gnomAD rs971095282, CADD 0.00, PolyPhen-2 0.00, Uncertain significance, not provided
- A29T (p.Ala29Thr), rs971095282, ClinGen CA287293717, ClinVar RCV003559725, TOPMed rs971095282, CADD 0.01, PolyPhen-2 0.00, Conflicting interpretations, not provided
- A29V (p.Ala29Val), rs1451762722, ClinGen CA397391217, ClinVar RCV002916230, ClinVar RCV003699002, CADD 7.38, PolyPhen-2 0.02, Uncertain significance, not provided; Inborn genetic diseases
- N30D (p.Asn30Asp), rs565040043, ClinGen CA8327658, ClinVar RCV001960476, ClinVar RCV005453425, CADD 1.80, PolyPhen-2 0.00, Uncertain significance, Inborn genetic diseases; not provided
- N30S (p.Asn30Ser), rs1388671158, ClinGen CA397391213, cosmic curated COSV99335, ClinVar RCV001946321, CADD 0.02, PolyPhen-2 0.00, Uncertain significance, not provided
- K31T (p.Lys31Thr), TOPMed rs1246421974
- A32V (p.Ala32Val), rs201338083, ClinGen CA8327657, ClinVar RCV002037240, ClinVar RCV004953125, CADD 0.17, PolyPhen-2 0.00, Conflicting interpretations, Inborn genetic diseases; not provided
- H33Q (p.His33Gln), ExAC rs757234714, gnomAD rs757234714, CADD 3.40, PolyPhen-2 0.15
- R35G (p.Arg35Gly), rs201788309, ClinGen CA8327653, ClinVar RCV002121453, ClinVar RCV003395411, CADD 3.94, PolyPhen-2 0.00, Conflicting interpretations, Inborn genetic diseases; not provided; NLRP1-related disorder
- R35S (p.Arg35Ser), TOPMed rs1905990966, CADD 3.29, PolyPhen-2 0.00
- S36G (p.Ser36Gly), Ensembl rs200961349
- S36N (p.Ser36Asn), gnomAD rs1359989730, CADD 7.94, PolyPhen-2 0.02
- S36R (p.Ser36Arg), Ensembl rs200166812
- S38A (p.Ser38Ala), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- S38L (p.Ser38Leu), cosmic curated COSV10499, NCI-TCGA TCGA novel, TOPMed rs1269596817, gnomAD rs1269596817, CADD 10.00, PolyPhen-2 0.01, Variant assessed as somatic; moderate impact.
- S38P (p.Ser38Pro), rs2508144319, ClinGen CA397391165, ClinVar RCV003116874, Uncertain significance, not provided
- S38W (p.Ser38Trp), TOPMed rs1269596817, gnomAD rs1269596817, CADD 20.80, PolyPhen-2 0.95
- G39S (p.Gly39Ser), rs774564239, ClinGen CA8327650, ClinVar RCV003399641, ExAC rs774564239, CADD 0.02, PolyPhen-2 0.00, Uncertain significance, NLRP1-related disorder
- G39V (p.Gly39Val), NCI-TCGA TCGA novel, CADD 0.73, PolyPhen-2 0.07, Variant assessed as somatic; moderate impact.
- E40K (p.Glu40Lys), rs766538219, ClinGen CA8327649, NCI-TCGA Cosmic COSV9933, cosmic curated COSV99333, CADD 7.74, PolyPhen-2 0.12, Uncertain significance, not provided
- T41A (p.Thr41Ala), rs200920244, ClinGen CA287293621, ClinVar RCV003698127, TOPMed rs200920244, CADD 0.05, PolyPhen-2 0.01, Uncertain significance, not provided
- T41I (p.Thr41Ile), rs1905986334, ClinGen CA397391143, ClinVar RCV003214243, ClinVar RCV005101301, CADD 6.46, PolyPhen-2 0.02, Uncertain significance, Inborn genetic diseases; not provided
- P42A (p.Pro42Ala), ExAC rs200014469, TOPMed rs200014469, gnomAD rs200014469, CADD 0.04, PolyPhen-2 0.01, Uncertain significance
- P42H (p.Pro42His), TOPMed rs1430167977, gnomAD rs1430167977, CADD 3.90, PolyPhen-2 0.02, Uncertain significance
- P42L (p.Pro42Leu), rs1430167977, ClinGen CA397391140, ClinVar RCV003060673, TOPMed rs1430167977, CADD 2.13, PolyPhen-2 0.01, Uncertain significance, not provided
- P42S (p.Pro42Ser), rs200014469, ClinGen CA8327648, ClinVar RCV002042387, ExAC rs200014469, CADD 0.12, PolyPhen-2 0.10, Uncertain significance, not provided
- P42T (p.Pro42Thr), rs200014469, ClinGen CA8327647, ClinVar RCV001991862, ClinVar RCV003170484, CADD 0.07, PolyPhen-2 0.01, Uncertain significance, not provided; Inborn genetic diseases
- A43G (p.Ala43Gly), rs2508144012, ClinGen CA397391136, ClinVar RCV003702758, CADD 12.90, PolyPhen-2 0.01, Uncertain significance, not provided
- A43T (p.Ala43Thr), rs145709003, ClinGen CA8327645, cosmic curated COSV99332, ClinVar RCV003580046, CADD 8.59, PolyPhen-2 0.07, Uncertain significance, not provided
- P45S (p.Pro45Ser), Ensembl rs971122274, CADD 1.42, PolyPhen-2 0.05
- E46Q (p.Glu46Gln), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- K47R (p.Lys47Arg), gnomAD rs1905983083, CADD 20.70, PolyPhen-2 0.54
- T48M (p.Thr48Met), rs368786124, ClinGen CA8327643, ClinVar RCV002039466, ExAC rs368786124, CADD 2.03, PolyPhen-2 0.00, Uncertain significance, not provided
- S49G (p.Ser49Gly), rs199880477, ClinGen CA287293523, cosmic curated COSV52580, ClinVar RCV001875220, CADD 2.12, PolyPhen-2 0.01, Uncertain significance, not provided
- M51I (p.Met51Ile), TOPMed rs1006424370, CADD 6.67, PolyPhen-2 0.16
- M51V (p.Met51Val), rs2508143770, ClinGen CA397391086, ClinVar RCV004495398, CADD 1.11, PolyPhen-2 0.11, Uncertain significance, Inborn genetic diseases
- E52K (p.Glu52Lys), gnomAD rs1275742245, CADD 15.90, PolyPhen-2 0.04
- E52Q (p.Glu52Gln), gnomAD rs1275742245
- V53G (p.Val53Gly), Ensembl rs1597494035
- V53L (p.Val53Leu), TOPMed rs953605073, gnomAD rs953605073, CADD 16.70, PolyPhen-2 0.15, Uncertain significance, not provided
- V53M (p.Val53Met), TOPMed rs953605073, gnomAD rs953605073
- A54T (p.Ala54Thr), rs1057519492, ClinGen CA16044249, ClinVar RCV000416558, ClinVar RCV006462606, CADD 23.20, PolyPhen-2 0.76, Pathogenic, not provided
- S55L (p.Ser55Leu), rs201750573, ClinGen CA8327641, ClinVar RCV001944839, ClinVar RCV002506915, CADD 23.30, PolyPhen-2 0.99, Uncertain significance, not provided; Corneal intraepithelial dyskeratosis-palmoplantar hyperkeratosis-l
- Y56* (p.Tyr56Ter), rs2151832864, ClinGen CA397391026, ClinVar RCV001876595, ClinVar RCV005238014, Uncertain significance
- L57M (p.Leu57Met), gnomAD rs1295474859, CADD 19.90, PolyPhen-2 0.42
- V58A (p.Val58Ala), TOPMed rs1905978144
- V58M (p.Val58Met), rs769494128, ClinGen CA287293486, ClinVar RCV002002582, ClinVar RCV003264351, CADD 23.10, PolyPhen-2 0.42, Uncertain significance, Inborn genetic diseases; not provided
- A59V (p.Ala59Val), cosmic curated COSV52570
- Q60H (p.Gln60His), ExAC rs745653895, TOPMed rs745653895, CADD 16.60, PolyPhen-2 0.60, Likely benign
- E63* (p.Glu63Ter), cosmic curated COSV99334, CADD 33.00
- E63K (p.Glu63Lys), 1000Genomes rs564787076, gnomAD rs564787076, CADD 19.80, PolyPhen-2 0.61
- E63Q (p.Glu63Gln), 1000Genomes rs564787076, gnomAD rs564787076, CADD 8.61
- Q64H (p.Gln64His), 1000Genomes rs541027765, ExAC rs541027765, gnomAD rs541027765, CADD 15.20, PolyPhen-2 0.06
- Q64R (p.Gln64Arg), cosmic curated COSV52573
- R65Q (p.Arg65Gln), rs200739115, ClinGen CA287293426, cosmic curated COSV10457, ClinVar RCV002005170, CADD 0.06, PolyPhen-2 0.00, Uncertain significance, not provided
- R65W (p.Arg65Trp), TOPMed rs1369797155, gnomAD rs1369797155, CADD 23.20, PolyPhen-2 0.68, Uncertain significance, Inborn genetic diseases
- A66S (p.Ala66Ser), TOPMed rs1397680252, CADD 16.60, PolyPhen-2 0.54
- A66V (p.Ala66Val), rs1057519493, ClinGen CA16044250, ClinVar RCV000416502, ClinVar RCV000479210, AlphaMissense 0.72, MetaLR 0.30, Likely pathogenic, not provided
- W67* (p.Trp67Ter), gnomAD rs1404528106, CADD 35.00
- D68G (p.Asp68Gly), rs2508143115, NCI-TCGA Cosmic COSV9933, cosmic curated COSV99334, ClinGen CA397390881, Uncertain significance, not provided
- A70S (p.Ala70Ser), cosmic curated COSV10805, CADD 19.70, PolyPhen-2 0.77
- L71F (p.Leu71Phe), rs2151832832, ClinGen CA397390849, ClinVar RCV002028615, Ensembl rs2151832832, CADD 5.01, PolyPhen-2 0.01, Uncertain significance, not provided
- H72D (p.His72Asp), gnomAD rs1463320467, CADD 16.00, PolyPhen-2 0.02
- H72Y (p.His72Tyr), cosmic curated COSV52562
- W74* (p.Trp74Ter), TOPMed rs1905971696, Uncertain significance
- W74L (p.Trp74Leu), rs1905971696, ClinGen CA397390808, ClinVar RCV003714799, TOPMed rs1905971696, CADD 7.09, PolyPhen-2 0.02, Uncertain significance, not provided
- W74R (p.Trp74Arg), Ensembl rs997782187, CADD 16.00, PolyPhen-2 0.03
- E75* (p.Glu75Ter), gnomAD rs1352759412, CADD 24.90
- E75K (p.Glu75Lys), cosmic curated COSV52573, CADD 0.61, PolyPhen-2 0.01
- Q76* (p.Gln76Ter), NCI-TCGA Cosmic COSV5257, cosmic curated COSV52576, CADD 32.00, Variant assessed as somatic; high impact.
- Q76R (p.Gln76Arg), TOPMed rs1169617829, gnomAD rs1169617829, CADD 6.96, PolyPhen-2 0.00
- M77T (p.Met77Thr), rs397514692, ClinGen CA018443, ClinVar RCV000043505, UniProt VAR 069901, AlphaMissense 0.90, MetaLR 0.14, Pathogenic, Corneal intraepithelial dyskeratosis-palmoplantar hyperkeratosis-laryngeal dyske
- L82Q (p.Leu82Gln), ExAC rs757173231, gnomAD rs757173231, CADD 19.70, PolyPhen-2 0.70
- C83Y (p.Cys83Tyr), gnomAD rs1196873238, CADD 15.20, PolyPhen-2 0.80
- A84P (p.Ala84Pro), 1000Genomes rs202167110, ExAC rs202167110, TOPMed rs202167110, gnomAD rs202167110, CADD 4.84, PolyPhen-2 0.64, Uncertain significance
- A84T (p.Ala84Thr), rs202167110, ClinGen CA8327635, cosmic curated COSV10457, ClinVar RCV001913943, CADD 0.11, PolyPhen-2 0.00, Conflicting interpretations, Inborn genetic diseases; not provided
- A84V (p.Ala84Val), TOPMed rs1905968506, CADD 15.30, PolyPhen-2 0.08
- Q85* (p.Gln85Ter), TOPMed rs200633502, gnomAD rs200633502, CADD 32.00
- Q85H (p.Gln85His), Ensembl rs1041395934
- A86P (p.Ala86Pro), cosmic curated COSV10457
- A86T (p.Ala86Thr), rs755043231, NCI-TCGA Cosmic COSV5256, cosmic curated COSV52561, ExAC rs755043231, CADD 9.12, PolyPhen-2 0.01, Variant assessed as somatic; moderate impact.
- Q87H (p.Gln87His), rs2508142536, ClinGen CA397390637, ClinVar RCV003700714, ClinVar RCV006368466, CADD 6.11, PolyPhen-2 0.00, Uncertain significance, not provided; Inborn genetic diseases
- E88D (p.Glu88Asp), TOPMed rs1905965845
- E88G (p.Glu88Gly), gnomAD rs1905966149, CADD 0.48, PolyPhen-2 0.00, Uncertain significance, not provided
- E88K (p.Glu88Lys), 1000Genomes rs562032379, ExAC rs562032379, TOPMed rs562032379, gnomAD rs562032379, CADD 0.90, PolyPhen-2 0.01, Uncertain significance, not provided
- G89E (p.Gly89Glu), rs766597944, ClinGen CA397390620, ClinVar RCV003734473, CADD 0.18, PolyPhen-2 0.00, Uncertain significance, not provided
- G89R (p.Gly89Arg), gnomAD rs1325799078, CADD 11.70, PolyPhen-2 0.01
- G89V (p.Gly89Val), ExAC rs766597944, gnomAD rs766597944, CADD 2.29, PolyPhen-2 0.01
- A90V (p.Ala90Val), gnomAD rs1330146972, CADD 19.90, PolyPhen-2 0.16
- G91D (p.Gly91Asp), rs2508132760, ClinGen CA397390322, ClinVar RCV003025234, Uncertain significance, not provided
- G91V (p.Gly91Val), cosmic curated COSV52565
- S93Y (p.Ser93Tyr), rs2508132702, ClinGen CA397390309, ClinVar RCV002301957, Uncertain significance, not provided
- P94S (p.Pro94Ser), rs777635766, NCI-TCGA Cosmic COSV5256, cosmic curated COSV52568, ExAC rs777635766, AlphaMissense 0.09, MetaLR 0.10, Variant assessed as somatic; moderate impact.
- S95* (p.Ser95Ter), cosmic curated COSV52565
- S95T (p.Ser95Thr), Ensembl rs1380432561
- F96L (p.Phe96Leu), gnomAD rs1290300693
- P97A (p.Pro97Ala), rs200363173, ClinGen CA8327614, ClinVar RCV001914114, ClinVar RCV005382272, CADD 0.46, PolyPhen-2 0.00, Uncertain significance, not provided; Inborn genetic diseases
- P97L (p.Pro97Leu), NCI-TCGA Cosmic COSV5257, cosmic curated COSV52573, Variant assessed as somatic; moderate impact.
- P97S (p.Pro97Ser), rs200363173, ClinGen CA8327613, ClinVar RCV002569908, ClinVar RCV005455550, CADD 1.42, PolyPhen-2 0.00, Uncertain significance, Inborn genetic diseases; not provided
- Y98C (p.Tyr98Cys), ExAC rs780060988, gnomAD rs780060988, CADD 0.07, PolyPhen-2 0.00
- S99R (p.Ser99Arg), ExAC rs750620188, TOPMed rs750620188, gnomAD rs750620188, CADD 15.50, PolyPhen-2 0.50
- P100L (p.Pro100Leu), TOPMed rs1905840004, gnomAD rs1905840004, CADD 4.18, PolyPhen-2 0.00
- E102K (p.Glu102Lys), cosmic curated COSV10499
- P103L (p.Pro103Leu), rs1247446949, ClinGen CA397390244, ClinVar RCV002301954, AlphaMissense 0.15, MetaLR 0.35, Uncertain significance, not provided
- P103R (p.Pro103Arg), TOPMed rs1247446949, gnomAD rs1247446949, AlphaMissense 0.15, MetaLR 0.35, Uncertain significance, not provided; Inborn genetic diseases
- P103S (p.Pro103Ser), Ensembl rs202194750, CADD 14.10, PolyPhen-2 0.55
- H104P (p.His104Pro), Ensembl rs1597492429
- H104Y (p.His104Tyr), rs762231366, ClinGen CA8327608, ClinVar RCV003881847, ExAC rs762231366, CADD 8.96, PolyPhen-2 0.03, Uncertain significance, not provided
- G106A (p.Gly106Ala), ExAC rs775062733, TOPMed rs775062733, gnomAD rs775062733, CADD 0.66, PolyPhen-2 0.04
- G106R (p.Gly106Arg), rs72827640, ClinGen CA8327606, cosmic curated COSV10728, ClinVar RCV000949999, CADD 6.60, PolyPhen-2 0.04, Benign/Likely benign, not specified; Respiratory papillomatosis, juvenile recurrent, congenital; Vitil
- G106V (p.Gly106Val), ExAC rs775062733, TOPMed rs775062733, gnomAD rs775062733, CADD 1.98, PolyPhen-2 0.07
- S107F (p.Ser107Phe), rs200126507, ClinGen CA8327603, ClinVar RCV001946536, ExAC rs200126507, CADD 11.20, PolyPhen-2 0.01, Uncertain significance, not provided
- S107P (p.Ser107Pro), Ensembl rs1567675373, CADD 15.40, PolyPhen-2 0.01
- P108A (p.Pro108Ala), rs141118572, cosmic curated COSV99335, ESP rs141118572, ExAC rs141118572, CADD 14.00, PolyPhen-2 0.22, Uncertain significance, not provided
- P108L (p.Pro108Leu), gnomAD rs1905835424, CADD 16.60, PolyPhen-2 0.04
- P108S (p.Pro108Ser), cosmic curated COSV10878
- S109R (p.Ser109Arg), TOPMed rs1905835118, gnomAD rs1905835118, CADD 15.40, PolyPhen-2 0.19
- Q110* (p.Gln110Ter), TOPMed rs979764619, gnomAD rs979764619, CADD 24.30
- Q110E (p.Gln110Glu), TOPMed rs979764619, gnomAD rs979764619
- T112P (p.Thr112Pro), Ensembl rs2151831675, CADD 22.40, PolyPhen-2 0.58
- S113C (p.Ser113Cys), cosmic curated COSV10878, TOPMed rs201858694
- S113F (p.Ser113Phe), rs201858694, NCI-TCGA Cosmic COSV5257, TOPMed rs201858694, AlphaMissense 0.24, MetaLR 0.39, Variant assessed as somatic; moderate impact.
- S113Y (p.Ser113Tyr), cosmic curated COSV52570
- A115S (p.Ala115Ser), ESP rs200012608, ExAC rs200012608, TOPMed rs200012608, gnomAD rs200012608, CADD 1.52, PolyPhen-2 0.14, Uncertain significance
- A115T (p.Ala115Thr), rs200012608, ClinGen CA8327597, cosmic curated COSV52579, ClinVar RCV002608668, CADD 2.26, PolyPhen-2 0.09, Uncertain significance, not provided
- V116M (p.Val116Met), rs2151831648, ClinGen CA397390176, ClinVar RCV002042156, Ensembl rs2151831648, AlphaMissense 0.26, MetaLR 0.40, Uncertain significance, not provided
- M118K (p.Met118Lys), ExAC rs748096457, gnomAD rs748096457
- M118T (p.Met118Thr), ExAC rs748096457, gnomAD rs748096457, CADD 0.00, PolyPhen-2 0.00
- M118V (p.Met118Val), Ensembl rs1014425352
- P119H (p.Pro119His), NCI-TCGA Cosmic COSV9933, cosmic curated COSV99332, Variant assessed as somatic; moderate impact.
- P119L (p.Pro119Leu), rs2151831639, ClinGen CA397390153, ClinVar RCV001986192, Ensembl rs2151831639, AlphaMissense 0.19, MetaLR 0.07, Uncertain significance, not provided
- P119S (p.Pro119Ser), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- W120* (p.Trp120Ter), cosmic curated COSV10728, CADD 29.50
- W120C (p.Trp120Cys), gnomAD rs1426999385, CADD 2.02, PolyPhen-2 0.00
- H122Q (p.His122Gln), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- H122R (p.His122Arg), cosmic curated COSV52570
- E123K (p.Glu123Lys), cosmic curated COSV52562, Ensembl rs867864593
- L124F (p.Leu124Phe), rs200978321, ExAC rs200978321, TOPMed rs200978321, gnomAD rs200978321, CADD 0.10, PolyPhen-2 0.01, Uncertain significance, not provided
- P125L (p.Pro125Leu), rs375872650, ClinGen CA8327594, cosmic curated COSV52562, ClinVar RCV001321044, CADD 4.16, PolyPhen-2 0.03, Uncertain significance, Inborn genetic diseases; not provided
- P125S (p.Pro125Ser), NCI-TCGA Cosmic COSV5255, cosmic curated COSV52558, Variant assessed as somatic; moderate impact.
- P125T (p.Pro125Thr), NCI-TCGA Cosmic COSV5255, Variant assessed as somatic; moderate impact.
- A126T (p.Ala126Thr), NCI-TCGA Cosmic COSV9933, cosmic curated COSV99333, CADD 2.81, PolyPhen-2 0.02, Variant assessed as somatic; moderate impact.
- A126V (p.Ala126Val), rs779228750, ClinGen CA8327592, NCI-TCGA Cosmic COSV5256, cosmic curated COSV52565, CADD 0.01, PolyPhen-2 0.00, Uncertain significance, not provided
- G127E (p.Gly127Glu), rs1905822749, ClinGen CA397390102, ClinVar RCV003428084, TOPMed rs1905822749, CADD 0.00, PolyPhen-2 0.00, Uncertain significance, not provided
- C128G (p.Cys128Gly), Ensembl rs1597492238
- Q130* (p.Gln130Ter), TOPMed rs1905820884
- Q130E (p.Gln130Glu), TOPMed rs1905820884
- Q130R (p.Gln130Arg), rs150929926, ClinGen CA8327590, ClinVar RCV001933377, 1000Genomes rs150929926, CADD 5.89, PolyPhen-2 0.08, Uncertain significance, not provided
Public NLRP1 analysis runs
- NLRP1 analysis run — NLRP1 (2,168 variants) — completed 2026-08-20